Coleneuramide

DB14932InvestigationalSmall molecule

Coleneuramide is under investigation in clinical trial NCT00307749 (Safety and Efficacy of MCC-257 in the Treatment of Diabetic Polyneuropathy).

Formula / weight: C₃₉H₆₈N₂O₈ · 692.979 g/mol (avg)
Code names: MCC-257

Resolves to

Compound

UNIIG2D52T65LRCAS204200-47-5ChEMBLCHEMBL2105634

Structure

InChIKeyCHMRTBYTCBDIRG-JQZMMWJVSA-NSMILES

CO[C@@]1(C[C@H](O)[C@@H](NC(C)=O)[C@@H](O1)[C@H](O)[C@H](O)CO)C(=O)N[C@@H]1CC[C@@]2(C)[C@@H](CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@H]23)C1

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of Coleneuramide, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account